Bristol-Myers Squibb (NYSE:BMY), a global biopharmaceutical ... be crucial in offsetting potential revenue declines from mature products. The biopharmaceutical industry continues to evolve rapidly ...

Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company involved in the research, development, licensing, manufacturing, marketing, and distribution of its products.

UnitedHealth is the largest U.S.-managed health care firm. The company provides ... Nearly $95 billion in long-term debt. Bristol-Myers Squibb is a global biopharmaceutical company that ...

If you’re on the fence about investing in AbbVie Inc or Bristol-Myers Squibb Co because you’re not sure how ... Restasis to increase tear production; and other eye care products. Further, it provides ...

If you’re on the fence about investing in Bristol-Myers Squibb ... products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in ...

Pascale Paimbault is a former senior director, of Compliance and Ethics at Bristol-Myers Squibb and Wright Medical ... doctors will be reluctant to reveal personal data. There is relatively ...

Few treatments have revolutionised care for people with chronic inflammatory disorders ... JBG has received honoraria from AbbVie, Biovitrum, Bristol Myers Squibb, Celgene, Chugai, Galapagos, Gilead, ...

Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE ... encompassing many companies that provide patient care, engage in the research and development of ...

AbbVie said it was disappointed with the results of its emraclidine trial for treating schizophrenia Bristol Myers Squibb Co. shares surged on Monday after rival AbbVie Inc. reported disappointing ...